Orange Book product · Brand (NDA)
METAXALONE
METAXALONE
At a glance
Jun 01, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 01, 2015
11 yr 3 mo ago
Today
Patent 11918559 expires
Listed drug product patent expiration.
Jul 29, 2039
in 13 yr 4 mo
Patent 12485111 expires
Listed drug product patent expiration.
May 14, 2043
in 17 yr 2 mo
Pharmaceutical detail
Active ingredient
METAXALONE
Strength
640MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 022503
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —SKELAXINBrand (NDA)
NDA 013217 · KING PHARMS
- 2020METAXALONEGeneric (ANDA)
ANDA 213836 · INGENUS PHARMS LLC
- 2020METAXALONEGeneric (ANDA)
ANDA 207466 · SCIEGEN PHARMS
- 2018METAXALONEGeneric (ANDA)
ANDA 208774 · RISING
- 2017METAXALONEGeneric (ANDA)
ANDA 203695 · ACTAVIS LABS FL INC
- 2016METAXALONEGeneric (ANDA)
ANDA 204770 · LANNETT CO INC
- 2015METAXALONEGeneric (ANDA)
ANDA 040486 · MOUNTAIN
- 2013METAXALONEGeneric (ANDA)
ANDA 203399 · AMNEAL PHARMS
- 2010METAXALONEGeneric (ANDA)
ANDA 040445 · SANDOZ
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11918559 | Jul 29, 2039 | in 13 yr 4 mo | Product |
| 12485111 | May 14, 2043 | in 17 yr 2 mo | ProductU-4453 |

